The Time is Now to Control Typhoid

Affiliations

¹ Oxford Vaccine Group, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, United Kingdom.
² Center for Vaccine Innovation and Access, PATH, Seattle, Washington.
³ Center for Vaccine Development and Global Health at the University of Maryland School of Medicine, Baltimore, MD.

Andrew J Pollard et al. Clin Infect Dis. 2019.

. 2019 Mar 7;68(Suppl 2):S47-S49.

doi: 10.1093/cid/ciy1115.

¹ Oxford Vaccine Group, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, United Kingdom.
² Center for Vaccine Innovation and Access, PATH, Seattle, Washington.
³ Center for Vaccine Development and Global Health at the University of Maryland School of Medicine, Baltimore, MD.

No abstract available

Keywords: TyVAC; typhoid; vaccine.

References

1. Adler R, Mara E.. Typhoid fever: a history. Jefferson, NC: McFarland & Co, 2016.
1. Sir William Jenner (1815–1898). JAMA 1970; 214:907–8. - PubMed
1. Global Burden of Disease. 2017.
1. Mogasale V, Maskery B, Ochiai RL, et al. . Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment. Lancet Glob Health 2014; 2:e570–80. - PubMed
1. Antillón M, Warren JL, Crawford FW, et al. . The burden of typhoid fever in low- and middle-income countries: a meta-regression approach. PLoS Negl Trop Dis 2017; 11:e0005376. - PMC - PubMed